Speakers
＊ The Speakers might change without any notation,
thank you for your understanding.
＊ The Speakers might change without any notation,
thank you for your understanding.
After graduating from Nagoya University School of Medicine, I received PhD from Kyoto University Graduate School of medicine. After that, I devoted myself to research in molecular biology for 20 years. In 2010, I decided that it would be nice to have a second chapter in my life, so I quit my research job and became an entrepreneur. I moved to Iwate Prefecture to test my business hypothesis on the theme of "revitalizing community healthcare in depopulated areas. After various social work activities and efforts to rebuild a medical corporation, I established Amvis, Inc. in 2013. I tested my business hypothesis of "a medical facility that outsources the function of doctors from hospitals" as a hospice business. In 2019, the company was listed on the JASDAQ. I aim that company will lasts 100 years by taking on the challenge of solving medical issues through innovation in mechanisms.
Yuko Joined NTT DOCOMO Ventures, Inc. in 2021 as President & CEO. Prior to joining NTT DOCOMO Ventures, Yuko was responsible for co-creating new innovative businesses with entrepreneurs inside NTT DOCOMO group through the “39works” program. Previously, Yuko created product line portfolios for smartphones, tablets and feature phones in NTT DOCOMO, as a product and service design specialist and co-developed the concept and technical specifications of i-mode service, an internet based service for mobile phones launched in 1999.
Outside of DOCOMO, Yuko is supporting and working with social entrepreneurs as a partner of ETIC. and REEP Foundation. Yuko also works as a mentor for younger generation employees from variety of companies.
Yuko holds an MBA from MIT’s Sloan Fellows Program (2013).
Joined IBM Japan in 1986. After serving as General Manager of the Public Agency System Division and the Software Division, Satoko was assigned to IBM Corporation in New York, and upon returning to Japan in 2009, she was appointed Vice President in charge of Security Business and Public Utilities. In 2019, joined Chugai.
He graduated from Hamamatsu Medical University in March 1980. He established Matsumoto Dermatology and Plastic Surgery Clinic in Omiya City (now Saitama City), Saitama Prefecture, in 1988. He served as Board Member in 1996 and Vice President in 2006 at the Omiya Medical Association. Afterwards, he served as Board Member in 2010 and Executive Board Member in 2011 at the Saitama Medical Association. After serving as President of the Omiya Medical Association in 2014, he served as Executive Board Member of the Japan Medical Association in 2016. From 2017 to 2021, he served as a member of the Ministry of Health, Labour and Welfare's "Central Social Insurance Medical Council". In June 2022, he was elected as the 21st President of the Japan Medical Association.
March 1997: Graduated from the University of Tokyo (B.A. in Law)
April 1997: Joined Ministry of Health and Welfare (MHW)
April 1997- July 2014: Health Policy Bureau, Minister’s Secretariat, Health and Welfare Bureau for the Elderly, Health Insurance Bureau, Social Welfare Bureau, Department of Health and Welfare for Persons with Disabilities, Office for Social Security of MHW/MHLW, and First Secretary at the Embassy of Japan in Washington, DC
July 2014-: Director, Office for Dementia, MHLW
June 2016-: Director for General Coordination, Minister’s Secretariat, MHLW
August 2017-: Secretary to the Minister of Health, Labour and Welfare
October 2018-: Director for General Coordination, Minister’s Secretariat, MHLW
September 2019-: Counsellor for General Coordination, Minister’s Secretariat, MHLW
September 2020-: Secretary to the Chief Cabinet Secretary
October 2021-: Director, Division for the Coordination of Health Care and Long-term Care, Health Insurance Bureau, MHLW
13years of experience as a doctor of obstetrician and gynecologist.Sending imformation about woman’s heath through all kinds of social media.On June 2022,a book written about woman's health and economy was published co-autherd by Takahumi Horie.Now director of THIRD CLINIC GINZA.
Dr.Fujimoto has worked as a business development manager etc in the healthcare at Medley Corporation, Link & Communication Corporation, and Toyota Tsusho Corporation Group. From 2021, he teaches courses in behavioral health science, health communication, and health care business. In his consulting firm specializing in healthcare, he has assisted more than 80 companies. His research specializes in structural analysis of service satisfaction, cost-effectiveness analysis, and PFS/SIB evaluation related to healthcare, and patients-practitioners communication.He received Ph.D. in Public Health from Kyoto University in 2019 and MBA from Hosei University in 2022. He is also an active investor in healthtech/foodtech.
At Cambridge Innovation Center (CIC), he leads the effort to develop CIC Tokyo, Japan's largest innovation center. CIC is the world’s leading operator of large shared offices/labs for startups, operating innovation centers in 8 cities worldwide. CIC Tokyo, opened in Oct. 2020, is a host for 230 companies and several innovation clusters, including healthcare, clean tech, and smart city among others.
As a KEARNEY partner, Umezawa has served leading corporations in Japan and the US for 25 years. Areas of his expertise include strategy, innovation, and organization.
At forStartups, Umezawa serves its board as an outside director. forStartups operates a talent recruiting business for startups, which is the market leader in Japan, and a venture capital.
Umezawa sits on government committees on innovation and intellectual property strategy, taxation, and tourism. He holds a bachelor of law from the University of Tokyo and an MBA from MIT Sloan School of Management.
Keiichi Murayama formerly served as the U.S. Silicon Valley bureau chief of Nikkei Inc., and was a senior staff writer and an editorial writer of Nikkei. After earning his undergraduate degree at Tohoku University in 1992, he joined the Business News Department of Nikkei in Tokyo as a staff writer. He covered technology, medical, automotive, and financial news. After he joined the Program on US-Japan Relations of Harvard University, he went on to oversee the U.S. Silicon Valley Bureau for a few years. He's authored "Rise and Fall of the IT Empire - Steve Jobs Revolution” and “STARTUP - Real of Entrepreneurs”.
Graduated from Pharmaceutical School of Gifu Pharmaceutical University in 2001.
Joined Johnson & Johnson Co., Ltd. in 2003
2006 Joined Sugi Pharmacy Co., Ltd.
In 2017 he took office as President and Representative Director of Sugi Pharmacy Co., Ltd.
In 2021 he took office as President and Representative Director of Sugi Holdings Co., Ltd.
By integrating the real and the digital with “health” as the keyword, we will strive to support your healthy and rich lives and enhance our corporate value and social value.
"Based on the philosophy of" wishing for the happiness of all people and increasing the smile ", we aim at the existence which can be relied upon from the community at ease, conveniently and casually.
Sho Okiyama, M.D.
Sho Okiyama is the CEO and founder of Aillis Inc., a Tokyo-based startup developing an AI device for early and accurate detection of influenza, and other infectious diseases. Sho is also a medical doctor specializing in emergency medicine who has worked as an emergency physician at the Japanese Red Cross Medical Center, as a flight doctor traveling on remote islands and as a ship's doctor. Prior to founding Aillis, he was the executive officer of the Japanese health care company Medley Inc. He earned his medical degree from the University of Tokyo in 2010.
With a Master’s Degree in Engineering from Kyoto University, Ryoichi joined McKinsey's Tokyo office in 2012, and the New Jersey branch since 2015, where he specialized in healthcare sector - pharmaceutical and medical device industries. After tackling a wide range of projects in Japan, the U.S. and Europe, including developing corporate strategies and beyond-the-pill initiatives using digital tools, he co-founded MICIN at the end of 2015 out of a keen awareness of the challenges in healthcare.
Joined Sumitomo Life Insurance Company after graduating from Kyoto University with a degree in Economics in 1988. After serving as General Manager of the Akita Branch Office in 2007, General Manager of the Marketing Planning Dept. in 2011, and Executive Officer and General Manager of the Corporate Planning Dept. in 2017, he became Senior Executive Officer and Managing Executive Officer (in charge of Customer Experience Planning Dept. and Vitality Business Strategy Dept., Deputy in charge of Corporate Planning Dept. and Marketing Planning Dept.) in 2018, and has been Director, President & Chief Executive Officer and Representative Executive Officer from April 2021.
An industrial physician who provides education and guidance to improve health literacy and resolve various health and communication issues that occur in the workplace, from mental health care to human resource development for workers.Concept director of information support and education for people with disabilities using ICT such as iPhone and iPad, and well-being hospital design. An ophthalmologist who prescribes information to people with information disabilities beyond the realm of medicine.A social physician who provides social prescriptions to solve social issues across fields such as welfare and education through training and writing activities based on dialogue.A physician and activist who conducts philosophical education on well-being for people to live abundantly in three styles.
Takayuki Shiga has served as president and co-founder of SmartShopping, Inc. since 2014. He previously led a start and growth of mobil adtech and social game business as Vice President at CyberAgent America, Inc. and President / CEO at AMoAd International, Inc. Earlier, he served in a role to lead M&A and fince projects at the UBS Investment Bank, after graduation of Graduate School of Informatica, Kyoto University in 2005.。
Joined Sumitomo Life Insurance Company in 1988. After being seconded to the Ministry of International Trade and Industry(at that time), became the Manager of the Secretarial Section, Corporate Governance Section. From 2011, handled launching the new brand strategy of Sumitomo Life, became the General Manager of the Brand Communication Department. From 2019, handled launching the Next Business Planning Department, and in the end of 2020, established "SUMISEI INNOVATION FUND", promoting Open Innovation in the area of construction of WaaS (Well-being as a Service) ecosystem, digital insurance business, and smart cities.
Tomoyuki Hattori is the founder and CEO of First Ascent Inc., a baby tech venture with the mission of "changing child-rearing through technology”. He is graduated from the Graduate School of Engineering at the University of Tokyo in 1998. After working as a researcher at Toshiba Corporation, he entered the IT industry. After working as CTO of a venture company and as a technology manager, he founded First Ascent Inc. in 2012.He has developed and provided "Papatto Ikuji”, a childcare record application that utilizes AI technology and know-how from joint research with the National Center for Child Health and Development, as well as "ainenne," an AI-powered sleep trainer with cry-analyzing technology.
Yumi Kawata, MD, PhD, is Founder and CEO of Hedgehog MedTech, Inc, a start-up Digital Therapeutics (DTx) company.
Previously, Yumi was a manager with SoftBank Corp, where she evaluated new Healthcare & Life Science investment opportunities, managed relationships with strategic partners. Prior to SoftBank, she was a Government Relations specialist with Medley, Inc, where she built and maintained the relationships with Ministry of Health, Labour and Welfare and Academia. She launched researches and POCs, contributing to the spread of telemedicine in Japan. She also served as a technical officer for MHLW. Yumi was involved in the management of researches on Rare and Intractable diseases and Infectious Diseases.
Kazuo Tsubota, MD, PhD, MBA is the CEO of Tsubota Laboratory, a start-up from Keio University School of Medicine, his alma mater, where he served as chair of the Department of Ophthalmology until 2021. He completed clinical and research fellowships at Harvard Medical School in 1987, and graduated from Keio Business School in 2019 with an executive MBA degree. An internationally recognized dry eye specialist, Prof. Tsubota has been working on the pathogenesis and treatment of dry eye for much of his career. His latest research activities spotlight myopia due to the myopia boom. His research focuses on the hypothesis that violet light has a suppressive effect against the progression of myopia. Prof. Tsubota was the first Japanese recipient of the American Academy of Ophthalmology Honor Award and received their Life Achievement Award in 2020.
After graduating from University of Environmental Health, He completed clinical training at Omori Red Cross Hospital in 2007. Between 2007 and 2009, he studied the practice of occupational physicians and was conducting research on preventive medicine at Occupational Health Training Center.
In 2009, He was an occupational physician of Johnson & Johnson k.k.
In 2014, He joined Doyukai medical corporation.
Currently, he is an medical adviser to 30 companies as an Occupational physician.
Doctor Kato is a board-certified ophthalmologist. He is engaging in the development of surgical instruments and telemedicine services while practicing as a doctor. He joined Ministry of Health, Labor and Welfare in 2016 and worked on setting regulations and generating policies as a deputy head of an office at the Deputy Head of the Health Policy Bureau. After leaving the the office, he established Aillis Inc., a company which is developing AI medical devices, as a co-founder. He is serving the company as a board member as well as the Executive Vice President and CSO. He also works for the Graduate School of Digital Hollywood University as a visiting professor. Currently, he teaches at 5 universities, runs a company, serves for 2 publicly listed companies as non-executive directors, takes roles of committee members for academic societies and the governments, and also practices at a university hospital.
Masatoshi joined dacadoo Japan in April 2021 and is currently in charge of Business Development in Japan.
After graduating from university, he joined a Japanese securities company. He then moved to an Australian IT venture company, where he was in charge of sales, implementation, and customer support for financial accounting systems.
In 2000, he moved to the financial division at PwC Japan. He has consistently worked with financial institution clients at several foreign and IT consulting firms, helping them formulate IT strategies, support business reforms, and assist in the integration of financial solutions.
Graduating from School of Integrated Health Sciences, Faculty of Medicine, The University of Tokyo, Mr. Shinjo started his career at an accounting consulting firm.
He then held a number of management positions in several internet-related companies.
In June 2021, he joined AxisRoot Holdings, Inc., where he has since been entrusted to develop new business opportunities and business planning.
Current position from May 2022.
Born:
February 18, 1984, Aichi Prefecture.
Education:
2008: Nagoya University, Faculty of Medicine
Career:
2012: First elected as the member of the Diet at the 46th General Election for the House of Representatives
2014: Elected to the House of Representatives for a second term in the 47th general election
2017: Parliamentary Secretary to the Minister of Finance.
2017: Third elected to the House of Representatives
2021: 4th elected to the House of Representatives. Director , Budget Committee / Health, Labor and Welfare Committee. Secretary general, Parliamentary Association for the Promotion of Health Tech .
2022: Chief Secretary Headquarters for Novel Coronavirus Measures, Policy Research Council
Daniel Lew is a Commercial Officer at the U.S. Embassy in Tokyo where he supports American companies entering the Japanese market. He oversees the following sectors: pharmaceuticals, medical technologies and devices, financial services, travel and tourism, education, and professional services including legal, accounting and consulting services. Before his position at the U.S. Embassy in Tokyo, he served at the U.S. Embassy in Seoul where he managed the transportation, energy, travel & tourism, and education sectors. Prior to working in Asia, he was at the Department of Commerce U.S. Export Assistance Center in Los Angeles where he created trading opportunities for companies entering foreign markets from the West Coast of the United States. Lew graduated from the University of Chicago with an MBA degree and holds a BS degree from the University of Massachusetts at Amherst. He is fluent in English and Korean, and conversant in Japanese.
Born in 1986, Jun Makuta is an NSCA Certified Personal Trainer (NSCA-CPT) and a Certified Strength and Conditioning Specialist (CSCS).
He began his career as a fitness trainer after his experience supporting athletes as a team trainer for a business handball team while in college.
After working at a gym, he started his own business and later became a critical member of the start-up of RIZAP.
He developed RIZAP's methods for training, diet, and goal achievement, and created an educational system to train the staff.
Graduated from Faculty of Policy Management, Keio University in 2003.
In his first career at PRAP Japan, largest independent PR agency in Japan, Takuya engaged in PR strategy planning for global IT vendors and consumer products manufacturers.
Joined DynaTrek, Inc. in 2009, currently in charge of corporate planning and marketing of DynaTrek.
Graduated from the Faculty of Policy Management, Keio University in 2006. Joined DYNATREK, Inc. in the same year. Currently in charge of planning, development and project management of DYNATREK, a data integration and analysis tool, as Director.
Also involved in obtaining patents in Japan, the U.S., China, and Singapore for the Data Connect algorithm of the tool, and advocates a data utilization tool that realizes "analysis that leads to action".
With strength in supporting business reforms using Data Connect technology, leads numerous data integration and utilization projects for financial institutions, government agencies, telecommunications companies, and electric power companies, etc. Currently promoting the use of this product, which has a market share of over 40% of Japan's regional banks, in the medical and life science fields.
She is a pediatrician at the intensive care and emergency department. She started to participated in operating "Health 2.0" from 2017.
1996 M.D. Faculty of Medicine, Gunma University, Maebashi, Japan
2005 Ph.D. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine
2006 M.P.H Master of Clinical Research, Kyoto University School of Public Health, Kyoto, Japan.
Professor of Department of preventive services, school of public health, graduate school of medicine, Kyoto university
President of the PHR Promotion Council.
Specialities: Clinical epidemiology, cardiology, resuscitation science, and health science.
I am working to improve the quality of PHR services and implement and develope them through industry-government-academia-private partnerships.
My future dream is to be a log-builder and a fisherman.
Ms.Mabuchi graduated from the Kyoto University of Government in 2011. She manages the assets of medical corporations as a trader. After that, she changed jobs to an analyst at The Japan Research Institute of Financial and Economic.
I’m a university student. I major in social welfare.I have a disability and bedridden. I am operating this OriHime from my home using a computer. I heard about the recruitment of OriHime pilots from my classroom teacher.
I was surprised, when I heard that. Because I never thought I can work!
I would like to work through OriHime. So I applied for the job, right away.
That’s how I got to became OriHime pilot.
I really enjoy working through OriHime.
I'm looking forward to meeting you.
In March 1999, graduated from Keio University Faculty of Law. In April 2000, joined Alfresa Corporation. Became the representative director of Specialty Medical Distribution Corporation, a subsidiary specializing in the distribution of specialty drugs, in June 2016, and engaged in the establishment of a unified distribution scheme for rare disease medicine. In June 2020, became the representative director of Alfresa Corporation.
Naoki Hotta joined Alfresa Corporation in October 2000. He worked in sales for 18 years before being assigned to the sales promotion office in the metropolitan area sales headquarters in 2019. He was in charge of Saitama, Kanagawa, Chiba and spent 2 years there developing sales strategies. After that, He was assigned to his current position in April 2021. He works on creating digital tools that contribute to the healthcare professionals with a focus on doctors and healthcare industry as well. He also works to help salespeople evolve into the next-generation.
Kenij Makino joined Alfresa Corporation in 1995. He worked in various departments such as purchasing, sales promotion, logistics and learned extensively about pharmceutical distribution.He served as a division manager of the specialty pharmaceuticals (2022.4),and then became the representative director of Specialty Medical Distribution Corporation, a subsidiary specializing in the distribution of specialty drugs (2022.6). He has engaged in the establishment of the comprehensive supply chain specializing rare disease medicine and Cell & Gene Therapy Products. "We quickly deliver drugs to patients with rare diseases and make them smile" With that in mind, He promotes The Smile Project for disease awareness and treatment support.
Anna is Principal at Sozo Ventures and Lead Partner at Portfolia, tapping into her unique understanding of the healthcare and business ecosystems in the US and Japan. Anna grew up and was educated in both countries; After attending medical school in Japan, she practiced as an OB/GYN in Tokyo, which gave her valuable insights into the clinical side of healthcare and the Japanese healthcare system. As a clinician, she led research on work-life-balance of physicians, and hosted many women’s health seminars to empower women. Wanting to have a broader impact on the healthcare ecosystem as a whole, she is now applying her experience as a clinician into supporting innovators. She is eager to bring people and ideas together to innovate a better future for healthcare in Japan and the US.
She holds an MD from the University of Tokyo, School of Medicine, and MBA from Stanford Graduate School of Business.
1999.
Moved to England during junior high school and graduated from Graduated from Central Saint Martins College of Art and Design.
July 2013
Started fashion brand "self-portrait" with Han Chung after graduating from university.
2018
Active beyond the field, participating in the production of the popular Youtube show "THIS IS MEVATANIKA" in Thailand.
2019
Founded PORTFOLIOS and started to develop a long-sought after vegan skincare brand "UNNATURALLY NATURAL".
She is also active in issues related to gender equality and women's empowerment and has given UN Women (UN agency speech). She is trilingual, speaking Japanese, English and Korean.
Born in 1984, Mago visited the slum in Ghana called Agbogbloshie in June 2017. There, he met local people who make a living by burning electronic devices which were disposed by the developed countries. Since then, he has produced art pieces using these electronic wastes, and with the sales of his art pieces, he delivered gas masks to the slums and established the slum's first school and cultural facility. Emmy Award winning director Kern Konwiser filmed his activities in Ghana and produced a documentary film. The film is currently being prepared for release. Mago advocates "Sustainable Capitalism," a new capitalism system in which the three axes of economy, culture, and environment (social contribution) are in a virtuous circle. He is working vigorously to transform the slum into a sustainable town by developing recycling, agriculture, and electric vehicle businesses to solve social issues.
While continuing to work as an emergency room (ER) physician, he was appointed as the Representative Director, CARADA medica Inc. in 2018 and the Representative Director, LIFEM Inc. in 2022. He is currently leading their online medical treatment and health consultation businesses, as well as the femtech service business which is provided to corporate clients as a wellness program.
Since he believes that people should take the initiative on self-health care he promotes awareness of self-health care and prevention regardless of generation or gender. His driving force is the desire to contribute to the realization of a society in which medical care permeates and more and more people can lead long healthy lives.
After working at Gree, Inc. and Recruit Holdings, Fumito Shimizu founded 3 Sunny, Inc. in August 2016 and became CEO. Based on his experience as a patient, he wanted to solve issues regarding medical and long-term care. He developed the Carebook web service series that connects medical and long-term care facilities applying solutions for arranging hospital discharge and transfer.
Registared Nurse, Public Health Nurse, Cirtified Care Worker, Care Manager, Scirtified Social Worker, Doctor of Health Sciences.
Assistant Professor, Kanazawa University Medical and Health Research Institute.
After working as a nurse at Tokyo Women's Medical University Hospital, I studied health science and medical economics at Osaka University Graduate School. While in graduate school, I worked as a public health nurse at a Community Comprehensive Support Center in Shinjuku Ward. I conducted statistical analysis data of long-term care in Shinjuku Ward and contributed to the policy planning of the ward.
Currently I'm enrolled at Kanazawa University as a researcher, focusing on analyzing health-related data held by public institutions such as KDB. I aim to conduct research that leads to social implementation. Policy recommendations based on field experience and statistics are highly evaluated by local government officials.
In 2007, I joined ASKEN, Inc. as a Registered Dietitian in charge of service planning and development. "Asken" has grown into one of the largest healthcare apps in Japan with over 8 million users.
Currently, I am in charge of the domestic business while also working as a registered dietitian.
Naoya Hashimoto is a board-certified pediatrician and founder and CEO of Kids Public Inc. Kids Public is the provider of Online pediatricians and Online OB-GYNs and midwives, which are 24/7 telehealth care for children, his/her family, and women with access to Pediatricians, OB-GYNs, and midwives through a smartphone, tablet, or computer. Originally from Tokyo, Japan, Naoya graduated from the Nihon University School of Medicine, and a master’s degree in public health from the University of Tokyo.
After graduating from Gifu Pharmaceutical University,engaged in drug development division, at Tanabe Seiyaku Co., Ltd. After the establishment of Mitsubishi Tanabe Pharma in October 2007, also served as the director of development division.After serving as Director of Product Strategy Department in 2014 and Director of Ikuyaku Division * Strategy Department in 2016, he became Executive Officer and Director of Ikuyaku Division in 2018 and Director and Managing Executive Officer in 2019, where he was in charge of Ikuyaku Division Director, Global RA, DX, and ICT management. As a director, he has been in charge of the strategic divisions such as business strategy, product strategy, business development, and DX since 2022, and was appointed the chairman of Japan Digital Health Aliance in the same year.
* Ikuyaku Division: Development Division and Medical Affairs Division
After graduating from the Science and Engineering Dept. at Keio University, engaged in project development projects for oil fields, power plant, etc. at Mitsui & Co., Ltd. After retirement, earned an MBA from Erasmus University in the Netherland, and moved to Novartis in 2002. Engaged in CIO office Japan, Global IT strategy and enterprise architecture in Switzerland, new digital organization set-up, etc. In 2016, took the CIO position at Miraca (current H.U. group) Holdings and established a new digital organization at the business side, and launched digital services for medical institutions and PHR business. Since 2021 joined in Mitsubishi Tanabe Pharma as CDO and driving ambidextrous DX including establishment of new digital businesses for patients and their families as well as transformation of internal value chain processes.
Pharmacist, PhD. Sports Pharmacist.
Joined Mitsubishi Tanabe Pharma in 2006 after receiving a degree from the Graduate School of Pharmaceutical Sciences, Nagoya City University.
Launched a new drug discovery project at the Pharmacology Laboratory, and engaged in electrophysiological experiments (in vivo & in vitro). In 2017,she entered an internal business idea contest and was transferred to the Future Design Department（currently Digital Transformation） in 2018. Driving ambidextrous DX including establishment of new digital businesses for patients and their families as well as transformation of internal value chain processes.including launching new digital businesses with patients and their families as the starting point.
Joined Mitsubishi Tanabe Pharma (formerly Mitsubishi Pharma) in 2006. After having engaged in pharmaceutical research and CMC project management for 7 years, seconded to the parent company, Mitsubishi Chemical Group (formerly Mitsubishi Chemical Holdings) through internal recruitment to engage in overseas M & A and PMI operations. Then moved to a new healthcare company, Life Science Institute, where involved in business planning and new business development. In 2018, returned to Mitsubishi Tanabe Pharma's Future Design Department (now Digital Transformation Department) to work on drug development support AI and digital medicine development. Currently, Striving to launch the business as a project leader of the lifestyle modification support app “TOMOCO”.
Hironao Yazaki is the Health Sciences and Wellness Leader and the Life Science Sector Leader at EY Japan. He provides audit services across the sector, including the pharmaceutical and medical equipment industry, bio ventures and hospitals.
Drawing on his extensive experience in life sciences and auditing, Hironao has served as local government commissioner, university lecturer, and as a committee member of the Japan Institute of Chartered Public Accountants (JICPA). He has also authored a guide to the impact of IFRS on the pharmaceutical industry.
Prior to joining EY, he worked in the manufacturing industry.
He is a Japan Certified Public Accountant and a graduate of the Faculty of Economics at Tokyo’s Keio University.
Tetsuro Sano is EY Japan Health Sciences and Wellness Consulting Leader, Life Sciences Sector Consulting Leader.
Having joined the firm in 2016, he provides management consulting services for life science companies in Japan and overseas, including the pharmaceutical and medical device sectors.
He advises clients on all aspects of the value chain, from medical and commercial to R&D and supply chains. He actively promotes business transformation in the life sciences industry, lecturing and holding seminars for industry companies and groups. He earned a master’s degree in finance from the London Business School and a master’s degree in management from the University of Oxford, both in the UK. He majored in accounting at Kentucky State University, USA.
Yuichiro Uchida joined Ministry of Internal Affairs and Communications (MIC) in 2006. He engaged in editing and compiling of the growth strategy for "Abenomics" at the Cabinet Secretariat in 2012-2014 and took part in establishing a public-private investment fund, Japan ICT Fund (JICT), at the ICT Policy Division, MIC, in 2014-2016. Uchida relocated to Vietnam in 2016 and was in charge of the Japan-Vietnam cooperation in the field of ICT, postal service, fire and disaster management, and e-Government at the Embassy of Japan. After moving back to Tokyo, he got involved in general coordination of the policy making at the Minister's Secretariat, MIC, in 2019-2020, and then worked on the PR strategy of the Suga Cabinet and the Kishida Cabinet at the Prime Minister’s Office as the Executive Secretary to the Cabinet Secretary for Public Affairs in 2021-2022. Uchida has taken his current post since July 2022.
Neith Inc.CEO&Founder
In 2004, she started her career as a singer-songwriter from Sony Music and Avex Inc.
In 2017, she was appointed as a brand director of an ice cream shop in Harajuku, the center of Japanese pop culture where survival is fierce for retailers. Through the use of social media marketing, the shop quickly became known as “the ice cream shop with a 3-hour line” and opened franchises in both Japan and abroad.
In 2020, she founded Neith Inc. with the desire to assist women maximize their performances by providing support to maintain a healthy body and mind, and bringing solutions to problems that are unique to women.
1978 Born in Kyoto
2000 Graduated University, Joined Fujitsu System Solutions Ltd. (currently Fujitsu Ltd.)
large-scale “entrusted development”, etc.
2005 Joined Kanamic Network, Executive Director
2011～ Joint researcher, The Institute of Gerontology, University of Tokyo
2012～ Visiting Researcher, National Cancer Center
2014 Representative Director and President of Kanamic Network (current position)
2016 Kanamic Network listed on the Mothers Market of the Tokyo Stock Exchange (TSE)
2018 Kanamic Network listed on the 1st Section of the TSE
2020 Director, The Tokyo New Business Conference (current position)
2022 Kanamic Network listed on the Prime Market of the TSE
2022 Chairman of URBAN FIT(current position)
Saho Murakami, MD, a board-certified ophthalmologist, and industrial physician, is a medical reviewer at PMDA.
Utilizing her experience as an MD, she is currently engaged in consultation and approval reviews of drugs, medical devices, and biological products at the PMDA. She is also involved in activities to educate employees about ophthalmologic diseases and to enhance work-life balance by utilizing her experience as an ophthalmologist and industrial physician. She graduated from the Faculty of Economics, Kyoto University, and the Okayama University Medical School.
I founded Cloud Clinic Co., Ltd in 2015.
As Japan is a super-aging society, more people hope to spend their last moments at home and it has been expanding the demand for home health care.
Aiming to achieve "a society where every person can live their own lives", we provide a service that does the complicated clerical work of clinics through our remote operations center by using cloud technology.
By sharing the doctor's clerical tasks, it reduces the burden on doctors and helps them focus on medical treatment.
Moreover, ICT enables us to design an employment system that encourages female healthcare professionals to start working for short hours even after they once left full-time work due to childbirth or other reasons of different life-stages, and we actively hire those who are continuously raising children or nursing their family members.
Due to this, we have continued to achieve the career development that leads management innovation.
Prior to joining Moderna, she was the CEO and Representative Director of Ferring Japan. She was also at Janssen Japan as the head of Medical Affairs Function and at Eisai Co., Ltd. as a corporate officer in charge of corporate business development. She obtained her Ph.D. in Medicine at University College London with a scholarship from Ludwig Institute for Cancer Research. Her postdoctoral research was on breast cancer at Imperial College, London.
MD, The University of Tokyo. Residency at Tokyo Metropolitan Geriatric Medical Center. Co-founded Ubie in 2017. Since 2019, he has been a member of the Special Committee for Activation of Research in Emergency AI of the Japanese Association for Acute Medicine. Nominated in Healthcare & Science category of Forbes 30 Under 30 Asia 2020.
March 2002 Bachelor of Laws, The University of Tokyo
April 2002 Joined Ministry of Economy, Trade and Industry（Consumer and Economic Policy Division）
Oct. 2004 Corporate Affairs Division, Economic and Industrial Policy Bureau
Jan. 2006 Industrial Revitalization Division, Economic and Industrial Policy Bureau
Jul. 2006 Secretariat of the Headquarters for Administrative Reform, Cabinet Secretariat（secondment）
Jan. 2008 Global Environmental Affairs Office, Industrial Science and Technology Policy and Environmental Bureal
April 2008 Environmental Economy Office, Industrial Science and Technology Policy and Environmental Bureal
Jul. 2011 Study abroad in the U.S.
Jul. 2012 Industrial Human Resources Policy Office, Economic and Industrial Policy Bureau
Jul. 2014 Nuclear Fuel Cycle Industry Division, Agency for Natural Resources and Energy
Jul. 2016 Policy Plannning and Coordination Division, Minister’s Secretariat
Jul. 2017 Policy Plannning and Coordination Division, Small and Medium Enterprise Agency
Jul. 2018 Suntory Holdings Limited (Seconded)
Jul. 2022 Director, Healthcare Industries Division, Commerce and Service Industry Policy Group
Atsushi Okabe
Senior Executive Manager of Healthcare Business Division, DMM.com, LLC.
CEO of DMM Online Clinic.
Vice President of DMC, a medical corporation.
Joined DMM.com in 2020 after serving as COO of an IT company, CSO of a consulting company and DX promotion company, and board member/secretary general of a medical industry association.
In 2021, establish DMM.com Healthcare Division and DMM Online Clinic, utilizing DMM.com's IT infrastructure and technology, which boasts 40 million members.
MISSION "Create the future of the healthcare industry
VISION "Always from the patient's perspective, create a new common sense of medical care" that is convenient and of high quality
Improve the quality of medical care as a leading QOL medical care company.
Shun Kuroiwa enrolled in Kyoto University School of Medicine in 2018 (currently in his 5th year). He is interested in innovation in the medical field and has interned at several medical venture companies and VC firms in Japan and abroad. He is now starting ZEROGATE, a platform that connects medical students and companies to create a starting point for innovators, based on the challenges he felt as a medical student in the Japanese healthcare ecosystem while studying abroad in Boston.
The representative of community based medical team "TEAM BLUE". Triggered by death of father, graduated medical school at the University of Tokyo. After engaging in overseas medical volunteer in Myanmar, started palliative home care clinic "Yamato clinic" in Tokyo in 2013 and has been supporting over 3000 patients spending their last days at home. Newly established a community based hospital "Lets go home hospital" in 2021.
He joined Allied Telesis in 1998. In 2013, he established the Medical Sales Department and was appointed as General Manager, and in 2015, he was appointed to his current position as General Manager of the Medical Sales Division, where he is engaged in expanding medical information nationwide. Currently, while coordinating projects in the medical field throughout Japan, he utilizes his wealth of knowledge and experience to make proposals that address the issues and requirements of his clients. https://www.allied-telesis.co.jp/
Takashi Matsumoto is a partner of EY Strategy and Consulting, Health Sciences and Wellness, Life science sector.
He provides management consulting services to domestic and international life science companies in the pharmaceutical and medical device fields.
He provides a wide range of consulting services including operational strategy development, organizational transformation, digital transformation, and CRO utilization strategies for departments such as medical affairs, pharmacovigilance, clinical development, quality assurance, and supply chain. He’s also given a lot of lectures at various industry associations and academic conferences.
Ryuichiro Umano is the Leader of Sustainability Disclosure Office of EY ShinNihon and supports initiatives to enhance a company's LTV (Long-Term Value) through disclosure as a member of EY Japan's LTV Promotion Office. He provides audit services across the sector, including the manufacturing, technology, retail and medical equipment industry, also provides assurance services on sustainability information such as energy consumption or GHG emission.
Drawing on his extensive experience in corporate reporting and auditing, Ryuichiro has served as a member of Corporate Disclosure Committee as well as the Auditing and Assurance Standards Committee at the Japan Institute of Chartered Public Accountants (JICPA).
He is a Japan Certified Public Accountant and a graduate of the Faculty of Policy Management at Tokyo’s Keio University.
I graduated from the University of Tokyo economic department in 2007.
My career is below.
- 2007~ Pharmaceutical Company / MR, Marketing
- 2012~ Medical Society / PR, Evemt Management, Business Development
- 2017~ MICIN / Business Development (Telemedicine/Telephaemacy) , Sales, Public Affiars, PR, HR, Business Manager
- 2022~ READYFOR / Lead Curator (Medical Category)
Work experience: Joined Yamanouchi Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.) in 1995. Since then, has experienced mainly marketing positions for medical drugs at Janssen Pharma, Novartis Pharma, and Shire Japan. Since March 2017, Joined PharmaEssentia in current position to launch and manage a Japan subsidiary. Leading strategy planning and execution. Currently, he is conducting domestic clinical trials and regulatory application work, aiming to obtain new drug approval in Japan.
Education: Graduated from the University of Wales School of Business (MBA), Kochi University Faculty of Science (Biology)
Learned teamwork and leadership from rowing he engaged in through students to adults.
Born in 1971, from Otsu City, Shiga Prefecture.
Joined the Kobe Branch Office of Sumitomo Life Insurance Company as a Life Designer (sales representatives) in 2005. After serving as a Sales Chief of the District Office, she trained and educated new Life Designers as a trainer. In 2013, she redeveloped her sales skills as a Life Designer of the Nagoya Sumirei Sales Promotion Office (to which a university graduate was assigned) and became a Sales Chief. In 2016, she engaged the development of "Sumitomo Life Vitality" as a member of the Vitality Project. Since the launch of "Sumitomo Life Vitality" in July 2018, she has been Manager in Charge of Vitality Business Marketing Sect. and engaged in sales promotion.
He joined The Dai-ichi Mutual Life Insurance Company (now The Dai-ichi Life Insurance Co., Ltd.) in 1997. Since then he has experience in branch offices, government as a trainee, Invest Planning Dept., Corporate Planning Dept., as well as IT Business Process Planning Dept.
From 2018 to 2020, he led the creation and promotion of innovation in Dai-ichi, first as general manager of Marketing Strategy Dept. and as Director of InsTech Development Center (Director of Dai-ichi Life Innovation Lab) of Dai-ichi Life Insurance, and then as Head of Innovation Strategy Group of Dai-ichi Life Holdings, Inc.
Since 2021, he has been president and CEO of QOLead, Ltd. and promoting the healthcare business of the Dai-ichi Life Group.
Risa Nakajima was born in 1998 and is currently a medical student at Kobe University. After winning the Miss Kobe University in 2020, she runs the YouTube "Risalemon" and searching for healthcare as an extension of entertainment. She is involved in public relations for the Japan Primary Care Association. She is also involved in the management of the media for medical students at HOKUTO Inc. She is interested in supporting people's health through dialogue and is keen to become a doctor who can provide better medical care that heals their bodies and minds. Her fields of interest are family medicine and women's health.
In 2002, after completing a master's degree at the University of Hawaii, he joined Convergence CT, Inc. in Hawaii, a venture company that collects and analyzes medical data for the efficient development and supply of pharmaceutical products.
As President of the subsidiary Convergence CT Japan K.K. (CCTJ), he was in charge of launching the Japanese market.
In 2019, he conducted an MBO of CCTJ and changed its name to 4DIN Ltd. He was appointed as Representative Director.
Darren Goff is the Director of Trade and Investment for Japan (based at the British Embassy in Tokyo) and the Deputy Trade Commissioner responsible for North East Asia. Darren leads a team across the Japan, South Korea and Taiwan markets focussed on strengthening commercial partnerships with the UK.
Darren has spent most of his career working for the Department for International Trade (DIT) and the Department for Business, Energy and Industrial Strategy (BEIS). Before moving to Japan in 2016 to head up the investment team, he led the Strategic Relationship Management Programme (SRM) in London which focussed on supporting the largest 80 foreign companies with UK operations and the largest 20 UK companies exporting from the UK. He is a qualified management accountant and previously headed up the Finance and Performance team focussed on investment in DIT.
MBA from the University of Wales, UK.
After working for a shipbuilding company in the biomass power generation business, he worked for a software development company and then for SMS Corporation, where he was involved in business development and managed M&A and incubation programs. He also has experience in operations in the medical and nursing care field, including the establishment and operation of a home nursing station. He then established a fund to create businesses by using hospitals and nursing care facilities as test fields, which Eucaria Inc. supports in its operations, and currently invests in startups as the representative of the fund.
Translated with www.DeepL.com/Translator (free version)
1991 Jichi Medical University, 1995 Stanford University School of Medicine, 2005 St.Marianna University School of Medicine, 2007 Johns Hopkins University School of Medicine. 2015 Professor, Advanced Biomedical Imaging Infomatics, 2018 Professor, Department of Medical Information and Communication Technology Research, 2019 Deputy Director, Digital Health Co-creation Center, St.Marianna University School of Medicine. My specialies are state-of-the-art CT/MRI, cardiovascular imaging, and medical AI and ICT. I was involved in joint development with several companies as a leader of the medical field side. I am the general manager of the human resource development project "Medical Innovator 2030” to create the future of medicine".
Exclusive designer for Axis Inc.
Joined Axis after working as a freelance designer.
He has been involved in various fields of design such as education, BtoB, and entertainment.
Currently, he is active as a creator and promoter of "Medixs," a cloud-based electronic drug history system.
He specializes in designs that take into account not only statistics but also emotional approaches.
Naohiro Itoyama graduated from Waseda University School of Law and joined P&G in 2005.
comprehensively led projects for hair care brands such as Vidal Sassoon, Pantene, and Wella. He also worked in Singapore as a brand manager and led the launch and growth of high-priced hair care brands in Japan and Asia.
In 2012, he joined Rakuten, Inc. He drove the launch and expansion of e-book and digital subscriber services. He was responsible for marketing, business management, and product and UI/UX development projects in Japan and Canada.
In 2020, he Joined the marketing conmany "Katana". He launched the business of hypertensive online medicine and became the CEO of e-Medical Japan Inc.
Mr.Fujioka graduated from the Kyoto University (Licensed Public Health Nurse and Nurse) and joined the Ministry of Economy, Trade and Industry (METI) in 2010. He launched organizations such as the Ministry's Healthcare Industries Division and Japan Agency for Medical Research and Development (AMED), as well as policies such as Health and Productivity Management and Japan Healthcare Business Contest. He was also transferred to the Ministry of Health, Labour and Welfare (MHLW), where he was involved in the launch of overall health promotion policies and PHR policies, and is currently responsible for overall healthcare policies at METI again. In addition, he is also involved in policies to solve social issues such as childcare and work system reform.
He joined The Dai-ichi Mutual Life Insurance Company (now The Dai-ichi Life Insurance Co., Ltd.) in 1997.
He has experience in Retail Dept., mobile phone company as a trainee, Corporate sales Dept., as well as he has been Deputy branch manager.
In 2021, he engaged in business development of healthcare as general manager of Business Development Group of Corporate Planning Unit.
Since 2022, he has been General Manager of Healthcare Task Force of Dai-ichi Life Insurance, and is promoting initiatives for further business development in the healthcare field.
Mr. Oishi joined SoftBank as a business strategist in May, 2018. He has been built alliances through negotiations with overseas companies, and proposed collaboration with customers and new business planning. Prior to joining SoftBank, he was in charge of joint venture projects in Southeast Asia, and established subsidiaries in India, Russia and UAE of GMO GlobalSign K.K. He has more than 10 years of experience in overseas expansion, operation and start-up management.
Born in Gunma Prefecture. Graduated from the University of Tokyo, Graduate School of Science, Chiba University School of Medicine, and the University of Colorado, Colorado Springs MBA. After working at Yokosuka U.S. Naval Hospital and Elsevier Japan, a medical publishing company, he founded Precision in 2016. He is also a researcher of artificial intelligence (AI).
・1990 Joined Nippon Life Insurance Company
・2018 General Manager of Human Resources Development
・2019 General Manager of Corporate Sales Dept.9
・2021 Director General Manager of Network Operations Department
・2022 Director General Manager of Healthcare Division
While working for a major IT company, I experienced burnout and took a temporary leave of absence. As a result, I realized the importance of dealing with mental health on a daily basis from a preventive perspective and launched MentaRest. We are working daily to develop services thoroughly from the user's perspective.
Although many companies are taking measures such as mandatory stress checks and the appointment of industrial physicians, the expected effect is the "early detection" of people with mental health problems, and there is a current situation in which it does not contribute to "prevention. However, the expected effect is "early detection" of people with mental disorders, not "prevention" of mental disorders.
By utilizing avatars in the Metaverse space, we will lower the psychological hurdle to use, and create a system that enables corporate employees to organize their thoughts and emotions and achieve stable performance.
Sarah Hamburg is a Scientist and Entrepreneur. After finishing her PhD in Cognitive Neuroscience, she worked in FinTech R&D (specialising in AI, emerging technologies, and global innovation). Recently, she has catalysed work at the intersection of science and blockchain (known as “Decentralised Science” – or simply, “DeSci”). This has involved working with numerous blockchain-based projects, co-founding a blockchain consultancy (phas3), and authoring articles on DeSci. She has a keen interest in Neuromorphic Computing and is starting a postdoc in this field.
Intensive Care Specialist, Pediatric Specialist/Preceptor. Graduated from Yamaguchi University School of Medicine in 2009. After working in the Department of Pediatrics at Kurume University Hospital and Hyogo Children's Hospital Pediatric Intensive Care Department, in 2020, he joined T-ICU Co., Ltd., which provides remote ICU services mainly for medical professionals. Utilizing his knowledge as a doctor, he is engaged in domestic and overseas businesses as CMO. He also participates as a core member in JICA's technical cooperation "Project for Strengthening Intensive Care Capacity under the COVID-19 Epidemic". 14 hospitals in 12 countries, which greatly exceeded the initial plan, were supported conclusively. In addition, he is focusing on supporting children who need medical care, and are leading the start of new projects, such as promoting collaboration with other organizations.
Mr.Kanayama guraduated the Graduate School of Agriculture and Veterinary Medicine at Nihon University and joined Henkel Japan Co., Ltd., a German company. He experienced in management positions of sales and marketing at Schwarzkopf, a cosmetics company. In 2011, he pursued an MBA degree from GLOBIS and launched a business study course in collaboration with the beauty industry and Meiji University. After retiring in 2014, he served as an advisor to multiple beauty dealers then he transferred to Arimino Co., Ltd. in 2016. He founded the marketing department in Arimino and became an advisor to the company in 2020. In April of the same year, he founded Japan Beauty Industrial Revitalization Company Limited. and became the CEO.
Lost his mother due to Alzheimer’s disease after the 10 years family fight, and decided to found a startup to contibute through reducing # of AD patients by developping innovative medical/non-medical approaches.
Worked as an executive for various Japanese and global large corporations such as Fuji Xerox, Sun Microsystems, Demension Data, AXA Life Insurance, Arthur D. Little etc.
Met the co-founder, Dr. Takashima through the Nikkei article and agreed to founc MIG.
Erned M.S. in Management from MIT Sloan School, B.E. in Mechanical Engineering, from Waseda Universitiy.
Yukinori Hasegawa worked on the development of medical information systems at Hitachi and Mitsubishi Electric. During that time, I was engaged in nuclear medicine research at Department of Radiology and Nuclear Medicine, Osaka University Graduate School of Medicine and Global Center for Medical Engineering and Informatics, Osaka University. After that, I was engaged in entrepreneurship research at Kyoto University Graduate School of Management and and now I support ventures at EPass. I established Renato Science in August 2021.
After graduating from Waseda University, he earned a master's degree in sociology from Ohio University. After working at Aeon Co. (distribution/retail), he was involved in setting up and managing overseas subsidiaries in the Philippines and China for a language e-learning venture. In 2018, he established WizWe Corporation. and developed "Smart Habit," a service that helps more than 90% of learners complete a course by making language learning a habit through human and digital support. Since 2020, he has been engaged in growing the business into a digital platform for habit creation in education and healthcare (Smart Habit Enterprise business) and for preventing subscription dropouts and maximizing LTV (Smart Habit LTV business).
Dr. Kitamura graduated from Fujita Health University in 2004. After completing her residency, she became a pulmonary surgeon. As she started studying pathology at Nagasaki University, she was faced with various challenges in the field of pathological diagnosis. Aiming to overcome such challenges, she established N Lab Co., Ltd which began by providing immunohistochemical staining and pathological analysis services for clinicians and researchers. Expanding its services to providing affordable scanners and cloud services for telepathology, N Lab further attempts to contribute to patients using an AI program developed by a research team in Nagasaki University. Dr. Kitamura continues her career as a surgeon and a pathologist in addition to business management, with a vision to develop tests and AI that truely supports health care providers.
March 1985 Graduated from Kyoto University Faculty of Law
1985-2000 Industrial Bank of Japan, Ltd.
ICT system development,
Singapore Branch, etc.
2001-2020 Various business development projects
Specialized in the healthcare and medical fields
Regenerative medicine, medical equipment, PHR, etc.
August 2020 ~ Established our company, President
Favorite Quote: Cross the Rubicon
Born in a remote area of Kochi, Japan.
After graduating from high school, entered the apparel industry. After working as a sales and designer, went on to dental school and became a dentist.
Since 2008, working at Kyoto University Hospital. The head of the ward medical director/outpatient medical director of the basic hospital, the head of the dental and oral surgery department of the regional basic hospital, the head of the department in the regional medical cooperation, and a part-time outpatient doctor for intractable diseases. Also obtained a number of certifications including training supervisor certification.
Founded SQRIE in 2018; retired from hospital in 2021 to begin full-fledged operations at SQRIE.
Born in 1991.
Dr. Nakada graduated from TMDU(Tokyo Medical&Dental University), and chose the path as a general practitioner.
He also studied the effect of mindfullness(meditation) in Waseda university.
He recognized the importance of preventive care, and established Wellness inc, in June 2018.
Wellness provides business people with personalized preventive care, and 250+ executives have joined this membership product.
He is supervising several books and magazines, in order to popularize evidenae-based healthcare.
Shinji Chiba, Ph.D in Medicine developed the game's base system at Hudson central research laboratory, then moved to Microsoft. After experienced a development of Windows OS for game consoles, provided technical support and SDK development as an early member of Xbox team. In recent years, conduct research and educational activities utilzing Microsoft innovative technologies such as Mixed Reality in a team that oversees Microsoft technologies. Shinji Chiba is also a part-time lecturer at Sophia University.
Graduated from Keio University School of Medicine in 2013. He specializes in dry eye. He has conducted numerous clinical and basic research studies on severe dry eye, especially those related to autoimmune diseases. In 2016, he started OUI Inc. (OUI Inc.). After returning from Vietnam, he invented the "Smart Eye Camera" which enables ophthalmological examinations anywhere and at any time by anyone, and after its commercialization, he developed it into a medical device that can be used for practical and practical purposes. After the invention and commercialization of the Smart Eye Camera, he succeeded in commercializing it as a medical device. Taking advantage of his position in academia, he pioneered the research and development of ophthalmic diagnostic AI for the anterior segment of the eye.
Yutaka Tomioka is the Head of Project Management Office for Medical Device Innovation at National Cancer Center Hospital East(NCCHE). He had been working with Pharmaceuticals and Medical Device Agency(PMDA) for over 10 years before working for NCCHE. He is one of the medical device regulatory experts in Japan. He works for not only NCCHE but a venture capital, incubators and start up companies as a regulatory advisor.
Yo is currently in his forth year at Keio University School of Medicine. After working as an engineer and biz-dev intern at a digital health venture, he is currently engaged in research on medical AI at his school while working with two medical device ventures regarding R&D and business strategy. He spent his childhood in China (Shanghai and Shenzhen) until he was 15 years old.
After graduating from the Faculty of Science and Technology at Keio University, he joined Nissho Iwai Corporation (currently Sojitz Corporation), where he was engaged in satellite broadcasting business.
After establishing several subsidiaries and being transferred to a strategic subsidiary, he became independent in 2006.
He founded Best Create Corp., and became its representative director.
As a pioneer in the store-based affiliate business, he has partnered with over 9,600 cell phone sales stores in Japan.
In 2011, he bought out the company through M&A. After serving as a director of AXEL MARK, a director of Monster Labs, and an executive officer of Geechs, he joined AXIS Root Holdings, Inc. and AXIS, Inc.
Matthew Holt, Co-Chairman, spent the 1990s learning from the best to be a health care futurist at Institute for the Future, and a survey researcher at Harris Interactive. In the early 2000s he spent time at a PHR start-up, but since he’s been the Founder of (and now occasional author on) The Health Care Blog, and co-founder of the Health 2.0 Conference–roles for which he was mostly self-taught!
President & CEO of Okapi Pharmacy System CO.LTD, which operates the online pharmacy “Todo Kusuri”. Also a Pharmacist.
After engaging in promotional activities at a pharmaceutical company, since 2007, he has been in charge of business development in the medical and healthcare fields at “Kenko.com” (name at that time), a company belonging to “Rakuten Group,Inc.”, “JINS Inc.”, and “LINE Corporation.”.
As an executive officer of "Kenko.com", he was involved in the implementation of the lifting of restrictions on the online sale of OTC drugs. He provided risk communication services to ensure that there is no trade-off between user convenience and safety in pharmaceuticals, a product that requires a high level of safety.
Currently, he also serves as General Manager of Healthcare Business Development Center of Toppan Inc. At there, he is involved in the realization of a healthy and long-lived society by utilizing medical big data with his members.